Artwork

Content provided by Dr. Brittany Barreto. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Brittany Barreto or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

AnelleO: 3D Printing the Future of Vaginal Drug Delivery

50:01
 
Share
 

Manage episode 484063741 series 2851689
Content provided by Dr. Brittany Barreto. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Brittany Barreto or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

📋 Episode Summary:
In this cutting-edge episode, Dr. Brittany Barreto sits down with Dr. Rahima Benhabbour—chemist, biomedical engineer, and founder of AnelleO, a UNC spinout transforming intravaginal drug delivery. With her roots in Algeria and her scientific training spanning three continents, Dr. Benhabbour brings a global, deeply human perspective to women's health innovation.

Together, they discuss how outdated vaginal ring technology inspired the development of AnelleO PRO, a 3D-printed, customizable progesterone ring designed for women undergoing fertility treatment. Unlike traditional rings that waste over 85% of the active drug, AnelleO's platform maximizes drug release and allows for multi-drug, multi-use configurations—including HIV prevention and contraception in a single product.

This episode is a must-listen for those interested in biotechnology, platform therapeutics, and the engineering breakthroughs reshaping reproductive care.

🧠 What You’ll Learn:

  • Why traditional intravaginal rings are inefficient and outdated

  • How AnelleO’s 3D printing technology allows for better drug release, fit, and personalization

  • The clinical and regulatory milestones leading to first-in-human trials for fertility care

  • How multi-purpose prevention technologies could transform global contraception and HIV care

  • The growing movement toward non-hormonal contraception and the future of male birth control

💬 Quotable Moment:
"Just because it’s hard doesn’t mean we shouldn’t do it. Someone has to pave the way." – Dr. Rahima Benhabbour

🔗 Resources Mentioned:

🧪 Episode Sponsor:
This episode is brought to you by:
Withum – A forward-thinking accounting and advisory firm supporting innovators in the Women’s Health and Wellness industry. Learn more at withum.com.

🍼 Nest Collaborative – The pioneers in telehealth lactation support. Book your virtual appointment with an International Board Certified Lactation Consultant at . Same-day visits often available and hundreds of insurance plans accepted, including Medicaid. www.nestcollaborative.com

  continue reading

260 episodes

Artwork
iconShare
 
Manage episode 484063741 series 2851689
Content provided by Dr. Brittany Barreto. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Brittany Barreto or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

📋 Episode Summary:
In this cutting-edge episode, Dr. Brittany Barreto sits down with Dr. Rahima Benhabbour—chemist, biomedical engineer, and founder of AnelleO, a UNC spinout transforming intravaginal drug delivery. With her roots in Algeria and her scientific training spanning three continents, Dr. Benhabbour brings a global, deeply human perspective to women's health innovation.

Together, they discuss how outdated vaginal ring technology inspired the development of AnelleO PRO, a 3D-printed, customizable progesterone ring designed for women undergoing fertility treatment. Unlike traditional rings that waste over 85% of the active drug, AnelleO's platform maximizes drug release and allows for multi-drug, multi-use configurations—including HIV prevention and contraception in a single product.

This episode is a must-listen for those interested in biotechnology, platform therapeutics, and the engineering breakthroughs reshaping reproductive care.

🧠 What You’ll Learn:

  • Why traditional intravaginal rings are inefficient and outdated

  • How AnelleO’s 3D printing technology allows for better drug release, fit, and personalization

  • The clinical and regulatory milestones leading to first-in-human trials for fertility care

  • How multi-purpose prevention technologies could transform global contraception and HIV care

  • The growing movement toward non-hormonal contraception and the future of male birth control

💬 Quotable Moment:
"Just because it’s hard doesn’t mean we shouldn’t do it. Someone has to pave the way." – Dr. Rahima Benhabbour

🔗 Resources Mentioned:

🧪 Episode Sponsor:
This episode is brought to you by:
Withum – A forward-thinking accounting and advisory firm supporting innovators in the Women’s Health and Wellness industry. Learn more at withum.com.

🍼 Nest Collaborative – The pioneers in telehealth lactation support. Book your virtual appointment with an International Board Certified Lactation Consultant at . Same-day visits often available and hundreds of insurance plans accepted, including Medicaid. www.nestcollaborative.com

  continue reading

260 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play